Prostate Cancer Screening: What Men Should Know About PSA Testing
Prostate cancer is one of the most common cancers affecting men. Many prostate cancers grow slowly and may never cause symptoms, but some can be aggressive. Screening can help identify cancer earlier, when treatment may be more effective. At Castle Rock Primary Care we follow urological guidelines to screen our male patients Schedule Now
What Is Prostate Cancer Screening?
The primary screening test is a prostate-specific antigen (PSA) blood test. PSA is a protein made by the prostate gland. A higher PSA level can be associated with prostate cancer, but it can also increase because of noncancerous conditions such as:
- Benign prostate enlargement
- Prostate inflammation or infection
- Recent ejaculation, cycling, or certain procedures
- Increasing age
A digital rectal examination (DRE) may sometimes be used as part of an evaluation, although the PSA test is the main screening tool.
When Should Men Consider Screening?
Prostate screening should be an individual decision made after discussing potential benefits and limitations.
In general:
- Men at average risk may consider beginning the discussion around age 50.
- Men at higher risk, including Black men and men with a father, brother, or son diagnosed with prostate cancer—particularly at a younger age—may benefit from discussing screening around age 45.
- Men with multiple close family members affected by prostate cancer may consider an even earlier conversation.
- Routine screening is generally not recommended for men with a limited life expectancy or for many men over age 70, though decisions should be individualized.
Benefits of PSA Screening
PSA screening may:
- Detect prostate cancer before symptoms develop
- Identify potentially aggressive cancer at an earlier stage
- Provide reassurance when PSA levels are stable or low
- Help guide further testing when appropriate
Limitations and Risks
An elevated PSA does not necessarily mean cancer is present. Abnormal results can lead to repeat testing, imaging, urology referral, or biopsy. Screening may also identify slow-growing cancers that would never have caused harm, potentially leading to anxiety or unnecessary treatment.
For this reason, an abnormal PSA result is usually evaluated in context rather than treated as an automatic indication for biopsy. Factors such as age, PSA trend over time, family history, prostate examination, prostate MRI findings, and other risk-assessment tools may help determine the next step.
Symptoms That Should Prompt Evaluation
Prostate cancer often causes no symptoms early on. However, men should seek evaluation for urinary or other concerning symptoms, including:
- Difficulty starting urination
- Weak urine stream
- Frequent urination, especially at night
- Blood in the urine or semen
- New erectile dysfunction
- Persistent bone pain or unexplained weight loss
These symptoms are commonly caused by conditions other than prostate cancer, but they deserve medical evaluation.
The Bottom Line
PSA screening is not a one-size-fits-all decision. The right approach depends on a man’s age, overall health, family history, race, personal preferences, and willingness to pursue additional evaluation if a result is abnormal. A thoughtful conversation about the potential benefits and downsides of screening can help men make an informed choice.
